
    
      This small, randomized, double blind, placebo controlled pilot study is aimed at determining
      the effects of four weeks of daily Immulina dietary supplementation (800 mg/day) versus four
      weeks of daily placebo on natural killer (NK) cell numbers and/or natural killer (NK) cell
      activity in human peripheral blood mononuclear cells collected from human research
      participants who meet the trial's inclusion/exclusion criteria.
    
  